Activities per year
- 12 results
Search results
-
Cost-Effectiveness Analysis of Diagnostic and Screening Strategies: When and How to Compare a Googolplex of Strategies? A case study in cascade screening for familial hypercholesterolaemia
Rita Faria (Speaker)
2 Dec 2021Activity: Talk or presentation › Oral presentation
-
Better Outcomes And Value For Money With Cost-Effectiveness Modelling Of Cascade Screening Strategies For Familial Hypercholesterolaemia
Rita Faria (Speaker)
1 Dec 2021Activity: Talk or presentation › Oral presentation
-
Lessons from cost-effectiveness analysis of screening for familial hypercholesterolaemia to the design of models of complex pathways
Rita Faria (Speaker)
Dec 2020Activity: Talk or presentation › Oral presentation
File -
Value and uncertainties in identifying the cost-effective sequence of tests
Rita Faria (Speaker)
17 Jul 2019Activity: Talk or presentation › Oral presentation
File -
Clarifying health gains and losses when communicating cost-effectiveness analysis
Rita Faria (Speaker)
15 Jul 2019Activity: Talk or presentation › Oral presentation
File -
Buy 1 get 2 free: cost-effectiveness analysis of cascade testing in familial hypercholesterolaemia
Rita Faria (Speaker)
26 Sept 2018Activity: Talk or presentation › Oral presentation
-
Lessons from a cost-effectiveness analysis of tests to diagnose clinically significant prostate cancer
Rita Faria (Speaker)
26 Sept 2018Activity: Talk or presentation › Oral presentation
-
Cost-effectiveness of diagnosis: tests, pay-offs and uncertainties
Rita Faria (Invited speaker)
17 May 2018Activity: Talk or presentation › Oral presentation
-
Cost-effectiveness of diagnosis: from tests to long-term outcomes and costs
Rita Faria (Speaker)
Nov 2017Activity: Talk or presentation › Oral presentation
-
'When and where in the treatment pathway is it appropriate to use new direct acting antivirals for chronic hepatitis C
Rita Faria (Speaker)
Jun 2016Activity: Talk or presentation › Oral presentation
-
Cost-effectiveness thresholds for health care: concepts and recent developments
Rita Faria (Speaker)
May 2016Activity: Talk or presentation › Oral presentation
-
Challenges in the evaluation and reimbursement of high-cost drugs for large patient populations: the controversy around the new drugs for hepatitis C
Rita Faria (Speaker)
May 2016Activity: Talk or presentation › Oral presentation